SMARCA4 and lung cancer: To more broadly assess cellular activity and determine whether the moderate selectivity in degradation translated to selective effects on cell growth, we profiled a panel of lung cancer models characterized by SMARCA4 mutation status (Fig. 3b, c, Supplementary Data 3).